A carregar...
Antithrombotic therapy in diabetes: which, when, and for how long?
Cardiovascular disease remains the main cause of mortality in individuals with diabetes mellitus (DM) and also results in significant morbidity. Premature and more aggressive atherosclerotic disease, coupled with an enhanced thrombotic environment, contributes to the high vascular risk in individual...
Na minha lista:
| Publicado no: | Eur Heart J |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8203081/ https://ncbi.nlm.nih.gov/pubmed/33764414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehab128 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|